StemCells Inc. (STEM) reported a fourth-quarter net loss of $2.76 million or $0.07 per share, compared to a net loss of $7.21 million or $0.47 per share in the fourth quarter of 2011.
Loss from operations in the fourth quarter of 2012 was $6,793,000, which was 7% lower compared to the fourth quarter of 2011.
Total revenue during the fourth quarter of 2012 was $211,000, compared to $541,000 in the same period of 2011. The decline was primarily due to higher revenue from licensing agreements in 2011. Total operating expenses in the fourth quarter of 2012 were $6,949,000, an 11% decrease compared to the fourth quarter of 2011.
Analysts polled by Thomson Reuters expected the company to report a loss of $0.14 per share on revenues of $310 thousand for the quarter. Analysts' estimates typically exclude special items.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.